# LifeSouth Community Blood Centers, Inc – FDA Inspection, Jul 24, 2018

Source: https://www.keypedia.com/records/fda_inspections/lifesouth-community-blood-centers-inc/510c53e9-312b-4eab-b8c4-f89fc33beb30
Source feed: FDA_Inspections

> FDA inspection 1061834 of LifeSouth Community Blood Centers, Inc, July 24, 2018. Classification: Voluntary Action Indicated (VAI). 12 citations under 21 CFR parts 211, 600 and 610. Form 483 issued. 11 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1061834
- Company Name: LifeSouth Community Blood Centers, Inc
- Inspection Date: 2018-07-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 12

## Related Documents

- [FDA Inspection 1318144 - 2026-05-21](https://www.keypedia.com/records/fda_inspections/lifesouth-community-blood-centers-inc/f716ca28-69a4-4cc1-a00f-f2dc7707e64c)
- FDA Inspection 1250489 - 2024-09-12
- [FDA Inspection 1222388 - 2023-11-09](https://www.keypedia.com/records/fda_inspections/lifesouth-community-blood-centers-inc/81245d9f-6f14-43af-b7b4-4a37f4a1e837)
- FDA Inspection 1180902 - 2022-09-08
- FDA Inspection 1122323 - 2020-02-27

## Related Officers

- [Company Rep](https://www.keypedia.com/people/jacqueline-m-diaz-albertini/9ff937fe-4e9b-445a-80fa-e26800d923b8)
- [Investigator](https://www.keypedia.com/people/justin-a-boyd/796c9c9d-02db-486c-bdca-cc259066a0e2)
- [Issuing Officer](https://www.keypedia.com/people/mercy-o-quagraine/c199b205-0142-43a0-ac9e-965aabf42265)

Company: https://www.keypedia.com/companies/lifesouth-community-blood-centers-inc/94ebe4e9-b648-4d51-a063-4ad00b617893

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
